These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15167638)

  • 1. Establishment of new cloned enzyme donor immunoassays (CEDIA) for haloperidol and bromperidol.
    Yasui-Furukori N; Saito M; Furukori H; Inoue Y; Someya T; Kaneko S; Tateishi T
    Ther Drug Monit; 2004 Jun; 26(3):336-41. PubMed ID: 15167638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor reliability of therapeutic drug monitoring data for haloperidol and bromperidol using enzyme immunoassay.
    Yasui-Furukori N; Furukori H; Saito M; Inoue Y; Kaneko S; Tateishi T
    Ther Drug Monit; 2003 Dec; 25(6):709-14. PubMed ID: 14639057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between steady-state plasma concentrations (Css) of bromperidol and haloperidol.
    Yasui N; Otani K; Kondo T; Suzuki A; Furukori H; Kaneko S; Inoue Y
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Apr; 22(3):485-92. PubMed ID: 9612845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of haloperidol and bromperidol and their reduced metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography.
    Yasui-Furukori N; Inoue Y; Chiba M; Tateishi T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(1):175-80. PubMed ID: 15113555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between carbamazepine and bromperidol.
    Otani K; Ishida M; Yasui N; Kondo T; Mihara K; Suzuki A; Furukori H; Kaneko S; Inoue Y
    Eur J Clin Pharmacol; 1997; 52(3):219-22. PubMed ID: 9218929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin response to bromperidol treatment in schizophrenic patients.
    Yasui N; Kondo T; Otani K; Ishida M; Mihara K; Suzuki A; Kaneko S; Inoue Y
    Pharmacol Toxicol; 1998 Mar; 82(3):153-6. PubMed ID: 9553995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma concentrations of bromperidol and its reduced metabolite with levomepromazine, but not with thioridazine.
    Suzuki A; Otani K; Ishida M; Yasui N; Kondo T; Mihara K; Kaneko S; Inoue Y; Shibata M; Ikeda K
    Ther Drug Monit; 1997 Jun; 19(3):261-4. PubMed ID: 9200764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of prolactin concentrations between haloperidol and bromperidol treatments in schizophrenic patients.
    Yasui-Furukori N; Kondo T; Suzuki A; Mihara K; Kaneko S; Otani K
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):575-8. PubMed ID: 11999910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No interaction between desipramine and bromperidol.
    Suzuki A; Otani K; Ishida M; Yasui N; Kondo T; Mihara K; Kaneko S; Inoue Y
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Oct; 20(7):1265-71. PubMed ID: 8938825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive bias in mycophenolic acid concentrations determined by the CEDIA assay compared to HPLC-UV method: is CEDIA assay suitable for therapeutic drug monitoring of mycophenolic acid?
    Dasgupta A; Johnson M
    J Clin Lab Anal; 2013 Jan; 27(1):77-80. PubMed ID: 23325745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characteristics of side-effects of bromperidol in schizophrenic patients.
    Yasui-Furukori N; Kondo T; Ishida M; Tanaka O; Mihara K; Kaneko S; Otani K
    Psychiatry Clin Neurosci; 2002 Feb; 56(1):103-6. PubMed ID: 11929578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depot bromperidol decanoate for schizophrenia.
    Wong D; Adams CE; David A; Quraishi SN
    Cochrane Database Syst Rev; 2004; (3):CD001719. PubMed ID: 15266450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Involvement of cytochromeP4503A4 in the metabolism of haloperidol and bromperidol].
    Furukori H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Feb; 18(1):9-14. PubMed ID: 9592806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromperidol decanoate (depot) for schizophrenia.
    Purgato M; Adams CE
    Cochrane Database Syst Rev; 2011 Sep; (9):CD001719. PubMed ID: 21901678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of various factors including the CYP2D6 genotype and coadministration of flunitrazepam on the steady-state plasma concentrations of bromperidol and its reduced metabolite.
    Suzuki A; Otani K; Mihara K; Yasui N; Kondo T; Tokinaga N; Furukori H; Kaneko S; Inoue Y; Hayashi K
    Psychopharmacology (Berl); 1998 Feb; 135(4):333-7. PubMed ID: 9539256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromperidol radioimmunoassay: human plasma levels.
    Tischio J; Hetyei N; Patrick J
    J Pharm Sci; 1984 Apr; 73(4):546-8. PubMed ID: 6726642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS; Taylor PJ; Salm P; Morris RG
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report.
    Suzuki A; Kondo T; Mihara K; Yasui-Furukori N; Otani K; Furukori H; Kaneko S; Inoue Y
    Eur Arch Psychiatry Clin Neurosci; 2001; 251(2):57-9. PubMed ID: 11407439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No effect of the anticholinergic drugs trihexyphenidyl and biperiden on the plasma concentrations of bromperidol and its reduced metabolite.
    Otani K; Ishida M; Yasui N; Kondo T; Mihara K; Suzuki A; Kaneko S; Inoue Y; Shibata M; Ikeda K
    Ther Drug Monit; 1997 Apr; 19(2):165-8. PubMed ID: 9108644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No pharmacokinetic but pharmacodynamic interactions between cisapride and bromperidol or haloperidol.
    Mihara K; Otani K; Yasui N; Ishida M; Kondo T; Suzuki A; Furukori H; Nagashima U; Kaneko S; Inoue Y
    Ther Drug Monit; 1999 Jun; 21(3):297-300. PubMed ID: 10365640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.